These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Kaposiform hemangioendothelioma with Kasabach-Merritt phenomenon in an infant: Successful treatment with prednisolone, vincristine, and addition of sirolimus. Cashell J, Smink GM, Helm K, Xavier F. Pediatr Blood Cancer; 2018 Dec; 65(12):e27305. PubMed ID: 30070028 [Abstract] [Full Text] [Related]
4. Sirolimus therapy for kaposiform hemangioendothelioma with long-term follow-up. Wang Z, Yao W, Sun H, Dong K, Ma Y, Chen L, Zheng S, Li K. J Dermatol; 2019 Nov; 46(11):956-961. PubMed ID: 31489702 [Abstract] [Full Text] [Related]
8. Successful Everolimus Treatment of Kaposiform Hemangioendothelioma With Kasabach-Merritt Phenomenon: Clinical Efficacy and Adverse Effects of mTOR Inhibitor Therapy. Matsumoto H, Ozeki M, Hori T, Kanda K, Kawamoto N, Nagano A, Azuma E, Miyazaki T, Fukao T. J Pediatr Hematol Oncol; 2016 Nov; 38(8):e322-e325. PubMed ID: 26907642 [Abstract] [Full Text] [Related]
9. Sirolimus Treatment of an Infant With Intrathoracic Kaposiform Hemangioendothelioma Complicated by Life-threatening Pleural and Pericardial Effusions. Duan L, Renzi S, Weidman D, Waespe N, Chami R, Manson D, Cada M, Carcao M. J Pediatr Hematol Oncol; 2020 Jan; 42(1):74-78. PubMed ID: 30044355 [Abstract] [Full Text] [Related]
11. Sirolimus as initial therapy for kaposiform hemangioendothelioma and tufted angioma. Wang H, Guo X, Duan Y, Zheng B, Gao Y. Pediatr Dermatol; 2018 Sep; 35(5):635-638. PubMed ID: 29999213 [Abstract] [Full Text] [Related]
12. Long-term outcomes of sirolimus treatment for kaposiform hemangioendothelioma: Continuing successes and ongoing challenges. Zhou J, Li Y, Qiu T, Gong X, Yang K, Zhang X, Zhang Z, Lan Y, Hu F, Peng Q, Zhang Y, Kong F, Chen S, Ji Y. Int J Cancer; 2023 Aug 01; 153(3):600-608. PubMed ID: 36916140 [Abstract] [Full Text] [Related]
13. NEWBORNS WITH KASABACH-MERRITT PHENOMENON-ASSOCIATED KAPOSIFORM HEMANGIOENDOTHELIOMA: A REPORT OF 6 CASES. Benzar IM, Rebenkov SO, Levytskyi AF, Fedoniuk LY, Fomina LV, Sas LM, Stravskyy TY. Wiad Lek; 2020 Aug 01; 73(8):1785-1789. PubMed ID: 33055352 [Abstract] [Full Text] [Related]
14. Development of Kasabach-Merritt phenomenon following vaccination: More than a coincidence? Ji Y, Chen S, Yang K, Xia C, Peng S. J Dermatol; 2018 Oct 01; 45(10):1203-1206. PubMed ID: 30118141 [Abstract] [Full Text] [Related]
15. Kaposiform Hemangioendothelioma with Kasabach-Merritt Phenomenon. Pati S, Das MK, Rana A, Das E, Sarkar S, Sherpa N, Datta S. Indian J Pediatr; 2021 Nov 01; 88(11):1142-1144. PubMed ID: 34106442 [Abstract] [Full Text] [Related]
16. Successful treatment of Kasabach-Merritt phenomenon arising from Kaposiform hemangioendothelioma by sirolimus. Wang Z, Li K, Dong K, Xiao X, Zheng S. J Pediatr Hematol Oncol; 2015 Jan 01; 37(1):72-3. PubMed ID: 24309604 [No Abstract] [Full Text] [Related]
17. Role of Sirolimus in Advanced Kaposiform Hemangioendothelioma. Oza VS, Mamlouk MD, Hess CP, Mathes EF, Frieden IJ. Pediatr Dermatol; 2016 Jan 01; 33(2):e88-92. PubMed ID: 26864138 [Abstract] [Full Text] [Related]
18. Successful treatment of Kaposiform hemangioendothelioma with everolimus. Uno T, Ito S, Nakazawa A, Miyazaki O, Mori T, Terashima K. Pediatr Blood Cancer; 2015 Mar 01; 62(3):536-8. PubMed ID: 25306933 [Abstract] [Full Text] [Related]
19. First Intracardiac Kaposiform Hemangioendothelioma in an Infant Resolved With Sirolimus: A Case Report. Zaidi SJ, Shaik S, Agrawal C, Cossor W. J Pediatr Hematol Oncol; 2018 Oct 01; 40(7):536-540. PubMed ID: 30067556 [Abstract] [Full Text] [Related]
20. Steroid-resistant kaposiform hemangioendothelioma: a retrospective study of 37 patients treated with vincristine and long-term follow-up. Wang Z, Li K, Yao W, Dong K, Xiao X, Zheng S. Pediatr Blood Cancer; 2015 Apr 01; 62(4):577-80. PubMed ID: 25346262 [Abstract] [Full Text] [Related] Page: [Next] [New Search]